Atomoxetine and Cerebrovascular Outcomes in Adults.

Trial Profile

Atomoxetine and Cerebrovascular Outcomes in Adults.

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2009

At a glance

  • Drugs Amphetamines; Atomoxetine; Methylphenidate; Mixed amfetamine salts
  • Indications Attention-deficit hyperactivity disorder
  • Focus Adverse reactions
  • Sponsors Eli Lilly
  • Most Recent Events

    • 18 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top